XL019
- Generic Name
- XL019
- Drug Type
- Small Molecule
- Unique Ingredient Identifier
- 4L1AM42NVA
- Background
XL019 is a selective inhibitor of the cytoplasmic tyrosine kinase JAK2. An IND for XL019 was filed by Exelixis in May 2007.
- Indication
For the treatment of various forms of cancer.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath